Product image of Minims (Pilocarpine Nitrate) supplied by GNH India

Minims

Active Ingredient:
Pilocarpine Nitrate
Origin:
EU

Minims (Pilocarpine Nitrate)

Pilocarpine nitrate, the active ingredient in Minims, is a miotic (muscarinic agonist) presented as an ocular preparation for eye use. It works by inducing pupil constriction and enhancing aqueous humor outflow, thereby reducing intra‑ocular pressure in patients with open‑angle glaucoma and ocular hypertension.\n\nGNH India supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics across global markets while adhering to stringent quality standards.

Manufacturer / TM Owner

Bausch + Lomb Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Pilocarpine nitrate is used in ocular therapy to manage conditions that involve elevated intra‑ocular pressure.\n\n- Open-angle glaucoma: reduces intra‑ocular pressure by increasing aqueous humor outflow.\n- Ocular hypertension: lowers intra‑ocular pressure to prevent progression to glaucoma.\n- Acute angle‑closure glaucoma: induces miosis to open the trabecular meshwork and facilitate pressure reduction.

How It Works

  • Pilocarpine nitrate acts as a direct agonist at muscarinic (M3) receptors on the sphincter pupillae and ciliary body. Stimulation of these receptors contracts the pupillary sphincter, producing miosis, and contracts the ciliary muscle, opening the trabecular meshwork. This enhances conventional outflow of aqueous humor, thereby decreasing intra‑ocular pressure. The drug also increases parasympathetic tone in the eye, contributing to improved fluid drainage.

Side Effects

  • Pilocarpine nitrate may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.\n\nCommon Side Effects:\n- Blurred vision: temporary difficulty focusing after instillation.\n- Eye irritation: burning or stinging sensation.\n- Headache: mild to moderate.\n- Increased tearing: excessive lacrimation.\n- Photophobia: sensitivity to light.\n- Brow ache: discomfort around the eyebrow.\n\nSerious or Rare Side Effects:\n- Retinal detachment: sudden visual loss requiring urgent care.\n- Severe allergic reaction: swelling, rash, or anaphylaxis.\n- Corneal ulcer: persistent eye pain and redness.\n- Persistent myopia: prolonged near‑sightedness after prolonged use.\n- Systemic cholinergic effects: bradycardia, hypotension, or bronchospasm.

Precautions & Warnings

  • Before prescribing Pilocarpine nitrate, clinicians should consider several safety measures.\n\n- Assess intra‑ocular pressure: confirm diagnosis and baseline measurements.\n- Monitor for allergic reactions: discontinue if signs of hypersensitivity appear.\n- Avoid in narrow‑angle glaucoma unless indicated: risk of further angle closure.\n- Use cautiously in patients with asthma or COPD: possible bronchospasm.\n- Caution with systemic anticholinergic therapy: may reduce ocular response.\n- Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

  • Pilocarpine nitrate can interact with other ophthalmic or systemic agents, affecting efficacy or safety.\n\nMajor Interactions (Avoid):\n- Systemic anticholinergics: may antagonize the miotic effect.\n- Other topical miotics: additive miosis can cause excessive pupil constriction.\n- Beta‑blocker eye drops combined with high‑dose pilocarpine: risk of profound intra‑ocular pressure reduction.\n\nModerate Interactions (Monitor Closely):\n- Topical non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of corneal toxicity.\n- Systemic cholinergic agents (e.g., physostigmine): may enhance systemic cholinergic side effects.\n- Contact lens wear: may reduce drug absorption and cause lens discomfort.

Frequently Asked Questions

Minims contains pilocarpine nitrate, a miotic eye drop that is prescribed to lower intra‑ocular pressure in conditions such as open‑angle glaucoma and ocular hypertension, helping to prevent optic nerve damage and preserve vision.

Pilocarpine nitrate binds to muscarinic receptors in the eye, causing the pupil to constrict and the ciliary muscle to contract. This opens the trabecular meshwork, allowing aqueous humor to drain more efficiently and thereby reducing intra‑ocular pressure.

The dosing regimen for Minims is determined by the prescribing ophthalmologist based on the patient’s condition, severity, and response to therapy. The prescriber will provide specific instructions on the number of drops and frequency.

Safety data for pilocarpine nitrate in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and consider alternative treatments if the safety profile is uncertain.

To order Minims, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minims (pilocarpine nitrate) is a miotic that lowers pressure by increasing outflow, whereas many other glaucoma drops, such as beta‑blockers or prostaglandin analogues, reduce production of aqueous humor. Choice of therapy depends on patient-specific factors, tolerability and target pressure goals.

Minims should be stored at room temperature, ideally below 25 °C. Keep the bottle in its original packaging, protect it from direct light and moisture, and ensure the cap is tightly closed to maintain sterility.

Minims is applied as an ocular drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place the prescribed number of drops into the conjunctival sac without touching the bottle tip to the eye.

Serious risks include rare but vision‑threatening events such as retinal detachment, severe allergic reactions, corneal ulceration, and systemic cholinergic effects like bradycardia or bronchospasm. Any sudden visual changes or systemic symptoms should prompt immediate medical evaluation.

Minims is contraindicated in patients with known hypersensitivity to pilocarpine or any component of the formulation, and it should be used with caution in individuals with narrow‑angle glaucoma, uncontrolled asthma, COPD, or those taking systemic anticholinergic medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pilocarpine Nitrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT